How strong is the relationship between glaucoma, the retinal nerve fibre layer, and neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis?

Eye
E Jones-Odeh, C J Hammond

Abstract

Glaucoma is a neurodegenerative disorder with established relationships with ocular structures such as the retinal nerve fibre layer (RNFL) and the ganglion cell layer (GCL). Ocular imaging techniques such as optical coherence tomography (OCT) allow for quantitative measurement of these structures. OCT has been used in the monitoring of glaucoma, as well as investigating other neurodegenerative conditions such as Alzheimer's disease (AD) and multiple sclerosis (MS). In this review, we highlight the association between these disorders and ocular structures (RNFL and GCL), examining their usefulness as biomarkers of neurodegeneration. The average RNFL thickness loss in patients with AD is 11 μm, and 7 μm in MS patients. Most of the studies investigating these changes are cross-sectional. Further longitudinal studies are required to assess sensitivity and specificity of these potential ocular biomarkers to neurodegenerative disease progression.

References

Dec 1, 1977·Archives of Ophthalmology·A SommerT George
Nov 22, 1991·Science·D HuangC A Puliafito
Feb 1, 1991·Archives of Ophthalmology·C S TsaiF Y Hsieh
Jan 1, 1991·Annals of Neurology·A Cronin-GolombK S Banks
Jan 1, 1990·Ophthalmology·A A Sadun, C J Bassi
Nov 6, 1989·Brain Research·J C BlanksC A Miller
Aug 21, 1986·The New England Journal of Medicine·D R HintonC A Miller
Dec 1, 1984·Archives of Ophthalmology·A SommerS Arkell
Jun 1, 1995·The British Journal of Ophthalmology·D C DaviesK A Jobst
May 1, 1995·American Journal of Ophthalmology·R N WeinrebL Zangwill
Dec 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·J IdiaquezR A San Martin
Mar 1, 1993·Annals of Neurology·C A Curcio, D N Drucker
Jan 29, 1998·The New England Journal of Medicine·B D TrappL Bö
Jun 1, 2000·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·F FotiouA Palikaras
Oct 12, 2001·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·V ParisiF Pierelli
Mar 27, 2002·European Neurology·A U BayerC Erb
Nov 27, 2002·Neurology·V I H KwaUNKNOWN Amsterdam Vascular Medicine Group
Dec 10, 2002·American Journal of Ophthalmology·Tien Yin WongA Richey Sharrett
Aug 21, 2003·Neurobiology of Aging·Atsuhiko IijimaYukito Shinohara
Sep 6, 2003·Frontiers in Bioscience : a Journal and Virtual Library·Stuart J McKinnon
Oct 7, 2004·Ophthalmology·Nicolaas J Reus, Hans G Lemij
Mar 10, 2005·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Stefano Da PozzoGiuseppe Ravalico
Apr 20, 2005·Japanese Journal of Ophthalmology·Shinji YonedaHidenobu Tanihara
Aug 3, 2005·Annals of Neurology·S Anand TripDavid H Miller
Jan 13, 2006·Ophthalmology·Jennifer B FisherLaura J Balcer
Mar 1, 2006·Investigative Ophthalmology & Visual Science·Kalliopi StasiJohn Danias
Mar 7, 2006·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Pervin K IseriNurşen Yüksel
Mar 28, 2006·Journal of the Neurological Sciences·Hiroki TamuraHiromu K Mishima

❮ Previous
Next ❯

Citations

Feb 24, 2016·Medical Journal, Armed Forces India·J K S Parihar
Mar 25, 2016·Clinical & Experimental Ophthalmology·Stuart L Graham, Alexander Klistorner
Aug 15, 2017·Current Opinion in Ophthalmology·Noel C Y Chan, Carmen K M Chan
Oct 29, 2019·Eye & Contact Lens·Matilde RodaPiera Versura
Nov 8, 2017·Scientific Reports·Marita Pietrucha-DutczakJoanna Lewin-Kowalik
Nov 1, 2017·Frontiers in Neurology·Javier MateoFrancisco Javier Ascaso
Mar 10, 2018·Current Medicinal Chemistry·Raffaele MancinoFrancesco Garaci
Jun 12, 2019·Translational Vision Science & Technology·Matthias M MauschitzMonique M B Breteler
Oct 6, 2020·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Oana M DumitrascuMaya Koronyo-Hamaoui
Feb 16, 2017·Oxidative Medicine and Cellular Longevity·Sankarathi BalaiyaKakarla V Chalam
Oct 19, 2019·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·A N BogolepovaA N Zhuravleva
Oct 8, 2020·International Journal of Molecular Sciences·Ajay AshokRithvik Ayyagari
Jan 5, 2021·Journal of Glaucoma·Aditya V BelamkarArthur J Sit
Oct 21, 2020·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Brooklyn Rawlyk, Balwantray C Chauhan
Apr 1, 2021·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Phillip H HwangAnnette L Fitzpatrick
May 13, 2019·American Journal of Ophthalmology·Richard F Spaide
Apr 24, 2021·Frontiers in Aging Neuroscience·Mengling YouDan Ji
May 25, 2021·Clinical Ophthalmology·Marta Para-PrietoJose Carlos Pastor
Nov 18, 2021·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Elena Garcia-MartinMaria J Rodrigo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.